Dr. Michael Zile, MD
NPI: 1760590707
Total Payments
$761,785
2024 Payments
$85,043
Companies
15
Transactions
588
Medicare Patients
6,036
Medicare Billing
$114,259
Payment Breakdown by Category
Consulting$411,126 (54.0%)
Research$296,142 (38.9%)
Travel$42,739 (5.6%)
Food & Beverage$5,272 (0.7%)
Education$4,931 (0.6%)
Other$1,575 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $411,126 | 243 | 54.0% |
| Unspecified | $296,142 | 155 | 38.9% |
| Travel and Lodging | $42,739 | 95 | 5.6% |
| Food and Beverage | $5,272 | 90 | 0.7% |
| Education | $4,931 | 3 | 0.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,575 | 2 | 0.2% |
Payments by Type
General
$465,643
433 transactions
Research
$296,142
155 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CVRx, Inc. | $312,112 | 166 | $0 (2024) |
| Medtronic Vascular, Inc. | $140,607 | 112 | $0 (2020) |
| Medtronic, Inc. | $110,968 | 114 | $0 (2024) |
| Eli Lilly and Company | $47,800 | 30 | $0 (2024) |
| Abbott Laboratories | $47,228 | 74 | $0 (2024) |
| Merck Sharp & Dohme LLC | $34,030 | 24 | $0 (2023) |
| Novartis Pharma AG | $23,089 | 25 | $0 (2021) |
| Boston Scientific Corporation | $15,517 | 21 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14,772 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $6,666 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85,043 | 72 | Medtronic, Inc. ($48,483) |
| 2023 | $162,008 | 85 | CVRx, Inc. ($96,831) |
| 2022 | $58,015 | 46 | Medtronic, Inc. ($17,821) |
| 2021 | $60,477 | 54 | CVRx, Inc. ($24,415) |
| 2020 | $82,545 | 54 | CVRx, Inc. ($33,373) |
| 2019 | $105,116 | 110 | CVRx, Inc. ($45,802) |
| 2018 | $80,470 | 63 | Medtronic Vascular, Inc. ($37,974) |
| 2017 | $128,113 | 104 | CVRx, Inc. ($46,642) |
All Payment Transactions
588 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Medtronic, Inc. | REVEAL LINQ (Device) | — | Cash or cash equivalent | $1,160.00 | Research |
| Study: ALLEVIATE-HF • Category: Cardiac Diagnostics and Monitoring | ||||||
| 12/03/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| 11/28/2024 | Medtronic, Inc. | ADAPTA (Device) | — | Cash or cash equivalent | $336.40 | Research |
| Study: FIRE-HFpEF • Category: Pacemakers | ||||||
| 11/05/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| 11/05/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 10/29/2024 | CVRx, Inc. | Barostim Neo System (Device) | — | Cash or cash equivalent | $1,100.00 | Research |
| Category: Heart Failure and Hypertension | ||||||
| 10/18/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,960.00 | General |
| 10/08/2024 | Medtronic, Inc. | ADAPTA (Device) | — | Cash or cash equivalent | $290.00 | Research |
| Study: FIRE-HFpEF • Category: Pacemakers | ||||||
| 10/07/2024 | Medtronic, Inc. | REVEAL LINQ (Device) | — | Cash or cash equivalent | $3,480.00 | Research |
| Study: ALLEVIATE-HF • Category: Cardiac Diagnostics and Monitoring | ||||||
| 10/04/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 10/04/2024 | Medtronic, Inc. | REVEAL LINQ (Device) | Food and Beverage | In-kind items and services | $86.80 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/28/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $250.00 | General |
| 09/26/2024 | CVRx, Inc. | Barostim Neo System (Device) | — | Cash or cash equivalent | $550.00 | Research |
| Category: Heart Failure and Hypertension | ||||||
| 09/26/2024 | Medtronic, Inc. | REVEAL LINQ (Device) | Food and Beverage | In-kind items and services | $141.21 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/26/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $47.29 | General |
| 09/26/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $28.78 | General |
| 09/26/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $17.18 | General |
| 09/25/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $47.55 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/24/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 09/24/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $280.00 | General |
| 09/24/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $102.00 | General |
| 09/24/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $11.35 | General |
| 09/23/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $102.00 | General |
| 09/23/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $38.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| INTERVENE-HF | Medtronic Vascular, Inc. | $61,589 | 19 |
| ALLEVIATE-HF | Medtronic, Inc. | $38,805 | 32 |
| INTERVENE HF | Medtronic Vascular, Inc. | $28,544 | 13 |
| ALLEVIATE-HF | Medtronic Vascular, Inc. | $18,878 | 15 |
| CLCZ696D2301 | Novartis Pharma AG | $13,648 | 13 |
| REVAMP | Medtronic Vascular, Inc. | $10,979 | 8 |
| FIRE-HFpEF | Medtronic, Inc. | $6,319 | 12 |
| REVAMP | Medtronic, Inc. | $1,050 | 1 |
| CLASP IIF (2018-07) | Edwards Lifesciences Corporation | $400.00 | 1 |
| Ventricle from Atrium | Medtronic Vascular, Inc. | $350.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,388 | 1,606 | $179,284 | $26,156 |
| 2022 | 9 | 1,629 | 1,946 | $205,488 | $29,042 |
| 2021 | 9 | 1,819 | 2,153 | $225,327 | $33,815 |
| 2020 | 10 | 1,200 | 1,397 | $157,271 | $25,246 |
Total Patients
6,036
Total Services
7,102
Medicare Billing
$114,259
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,165 | 1,356 | $101,700 | $8,113 | 8.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 35 | $18,200 | $3,925 | 21.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 37 | $12,950 | $3,185 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 48 | 51 | $13,209 | $2,990 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 22 | 28 | $10,892 | $2,949 | 27.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 35 | 37 | $9,065 | $2,253 | 24.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 34 | $7,820 | $2,035 | 26.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 16 | $2,544 | $599.84 | 23.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 12 | 12 | $2,904 | $105.80 | 3.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,399 | 1,676 | $125,700 | $10,420 | 8.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 38 | $19,760 | $5,303 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 47 | 58 | $14,326 | $3,584 | 25.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 42 | $14,700 | $3,239 | 22.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 40 | $9,200 | $2,162 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 14 | 16 | $5,979 | $1,665 | 27.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 28 | 29 | $7,105 | $1,575 | 22.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 32 | $5,088 | $939.29 | 18.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 15 | 15 | $3,630 | $155.20 | 4.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 1,553 | 1,852 | $138,900 | $11,957 | 8.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 45 | $23,246 | $6,879 | 29.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 45 | 49 | $16,115 | $3,772 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 42 | 49 | $10,603 | $3,449 | 32.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 24 | 25 | $7,980 | $2,280 | 28.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 38 | 40 | $9,512 | $2,236 | 23.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 40 | $9,050 | $2,115 | 23.4% |
About Dr. Michael Zile, MD
Dr. Michael Zile, MD is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760590707.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Zile, MD has received a total of $761,785 in payments from pharmaceutical and medical device companies, with $85,043 received in 2024. These payments were reported across 588 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($411,126).
As a Medicare-enrolled provider, Zile has provided services to 6,036 Medicare beneficiaries, totaling 7,102 services with total Medicare billing of $114,259. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Cardiovascular Disease
- Location Charleston, SC
- Active Since 08/29/2006
- Last Updated 11/07/2025
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1760590707
Products in Payments
- Barostim Neo System (Device) $312,112
- Viva (Device) $97,511
- REVEAL LINQ (Device) $31,319
- Reveal LINQ (Device) $30,061
- CardioMEMS HF System (Device) $28,502
- STEGLATRO (Drug) $11,217
- Adapta (Device) $10,979
- LCZ696D (Drug) $9,577
- LCZ696B (Drug) $9,007
- GENERAL THERAPIES (Device) $8,304
- CARDIOMEMS (Device) $8,281
- ENTRESTO (Drug) $7,891
- ADAPTA (Device) $7,369
- GENERAL - THERAPIES (Device) $5,199
- Mitra Clip system (Device) $3,649
- Assure WCD (Device) $3,200
- HeartMate 3 Left Ventricular Dev (Device) $2,070
- LCZ696B_ENTRESTO_CARDIOVASCULAR (Drug) $1,960
- HeartWare HVAD (Device) $1,926
- sGC $1,350
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Advanced Heart Failure and Transplant Cardiology Doctors in Charleston
Jan Griffin, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $4,127
Advanced Heart Failure and Transplant Cardiology $4,127
Heather Henderson, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $655.85
Advanced Heart Failure and Transplant Cardiology $655.85
Mabelissa Geagea, Md, MD
Advanced Heart Failure and Transplant Cardiology
Advanced Heart Failure and Transplant Cardiology